# A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride

> **NCT04754373** · PHASE2 · COMPLETED · sponsor: **BIO-CAT Microbials, LLC** · enrollment: 37 (actual)

## Conditions studied

- Elevated Triglycerides

## Interventions

- **DIETARY_SUPPLEMENT:** GFA-918
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04754373
- **Lead sponsor:** BIO-CAT Microbials, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-13
- **Primary completion:** 2021-12-06
- **Final completion:** 2021-12-06
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2021-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04754373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04754373, "A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04754373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*